HSP90-IN-11
HSP90-IN-11 is a HSP90 inhibitor with an IC50 of 27.8 nM. HSP90-IN-11 inhibits the activity of HSP90, which in turn induces rapid degradation of EGFR and Akt proteins in non-small cell lung cancer (NSCLC) cells. HSP90-IN-11 induces accumulation of the G1 subphase cell population in NSCLC cells, activates caspase-3, caspase-8, caspase-9 and PARP, thereby triggering apoptosis. HSP90-IN-11 exhibits antiproliferative activity in colorectal cancer and NSCLC cells. HSP90-IN-11 can be used for the research of colorectal cancer and non-small cell lung cancer.
For research use only. We do not sell to patients.
- CAS No.: 2986564-20-7
- Formula: C27H30FN3O6
- Molecular Weight:511.54
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
HSP90 27.8 nM (IC50) |
Caspase 3 |
Caspase-8 |
Caspase-9 |
EGFR |
PARP |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | GI50 |
0.07 μM
Compound: 12c
|
Antiproliferative activity against human A549 cells measured after 48 hrs by SRB assay
Antiproliferative activity against human A549 cells measured after 48 hrs by SRB assay
|
[PMID: 32683166] |
| HCT-116 | GI50 |
0.01 μM
Compound: 12c
|
Antiproliferative activity against human HCT-116 cells measured after 48 hrs by SRB assay
Antiproliferative activity against human HCT-116 cells measured after 48 hrs by SRB assay
|
[PMID: 32683166] |
| NCI-H1975 | GI50 |
0.04 μM
Compound: 12c
|
Antiproliferative activity against human NCI-H1975 cells measured after 48 hrs by SRB assay
Antiproliferative activity against human NCI-H1975 cells measured after 48 hrs by SRB assay
|
[PMID: 32683166] |
| NCI-H460 | GI50 |
0.06 μM
Compound: 12c
|
Antiproliferative activity against human NCI-H460 cells measured after 48 hrs by SRB assay
Antiproliferative activity against human NCI-H460 cells measured after 48 hrs by SRB assay
|
[PMID: 32683166] |
In Vitro
HSP90-IN-11 (compound 12c) (2-3 h) potently inhibits recombinant HSP90α with an IC50 of 27.8 nM[1].
HSP90-IN-11 binds to the HSP90 (PDB ID: 5GGZ) binding pocket via four distinct sites, forming multiple hydrogen bonds and hydrophobic interactions that align with the binding mode of AUY-922, with additional stable interactions at Site 4 that support its potent inhibitory activity[1].
HSP90-IN-11 (48 h) potently inhibits the proliferation of colorectal cancer HCT116 cells with a GI50 of 0.010 μM[1].
HSP90-IN-11 (48 h) potently inhibits the proliferation of NSCLC A549, H460, and H1975 cells with GI50 values of 0.07 μM, 0.06 μM, and 0.04 μM, respectively, with greatest activity against EGFR-mutant H1975 cells[1].
HSP90-IN-11 (0.004-0.15 μM; 24 h initial treatment; followed by 10 days of drug-free growth) inhibits colony formation in colorectal cancer HCT116 cells and NSCLC A549, H1975 cells in a concentration-dependent manner, with greater activity against the NSCLC cell lines at 0.009 and 0.018 μM[1].
HSP90-IN-11 (0.075-1.25 μM; 24 h) activates HSP70 expression and downregulates HSP90 client proteins EGFR and Akt in a concentration-dependent manner in NSCLC A549 and H1975 cells after 24 h of treatment[1].
HSP90-IN-11 (0.15-2.5 μM (A549); 0.075-1.25 μM (H1975); 48 h) induces concentration-dependent sub-G1 phase accumulation (apoptotic cell death) in NSCLC A549 and H1975 cells after 48 h of treatment[1].
HSP90-IN-11 (0.15-2.5 μM; 48 h) induces concentration-dependent activation of caspase-3, -8, -9, PARP, and γH2AX, markers of apoptosis and DNA damage, in NSCLC A549 and H1975 cells after 48 h of treatment[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Colorectal cancer HCT116 cells, NSCLC A549, H1975 cells
-
Concentration:0.004 μM; 0.009 μM; 0.018 μM; 0.0375 μM; 0.075 μM; 0.15 μM
-
Incubation Time:24 h (initial treatment; followed by 10 days of drug-free growth)
-
Result:Showed concentration-dependent inhibition of colony formation in all three cell lines.
At 0.009 and 0.018 μM, exhibited stronger inhibitory effects on colony formation in A549 and H1975 cells than in HCT116 cells.
Statistically significant inhibition was observed at concentrations ≥0.018 μM in HCT116 cells, ≥0.009 μM in A549 cells, and ≥0.009 μM in H1975 cells.
-
Cell Line:NSCLC A549 and H1975 cells
-
Concentration:0.075 μM; 0.15 μM; 0.3 μM; 0.6 μM; 1.25 μM
-
Incubation Time:24 h
-
Result:Induced a concentration-dependent increase in HSP70 expression (a marker of HSP90 inhibition) in both cell lines, without altering HSP90 levels.
Concurrently, caused a concentration-dependent reduction in the HSP90 client proteins EGFR and Akt in both A549 and H1975 cells.
-
Cell Line:NSCLC A549 and H1975 cells
-
Concentration:0.15-2.5 μM (A549); 0.075-1.25 μM (H1975)
-
Incubation Time:48 h
-
Result:Induced a concentration-dependent accumulation of cells in the sub-G1 phase (a marker of apoptotic cell death) in both A549 and H1975 cells.
In A549 cells, significant sub-G1 accumulation was observed at all tested concentrations; in H1975 cells, significant sub-G1 accumulation was observed at concentrations ≥0.075 μM.
-
Cell Line:NSCLC A549 and H1975 cells
-
Concentration:0.15 μM; 0.3 μM; 0.6 μM; 1.25 μM; 2.5 μM
-
Incubation Time:48 h
-
Result:Induced a concentration-dependent increase in the cleaved (activated) forms of caspase-3, caspase-8, caspase-9, and PARP, along with increased γH2AX expression, in both A549 and H1975 cells.
Chemical Information
-
CAS No. 2986564-20-7
-
Molecular Weight 511.54
-
Formula C27H30FN3O6
-
SMILES
CCN(C1=CC=C(C=C1)CN2C(C(F)=CN(C2=O)C3CCCO3)=O)C(C4=CC(C(C)C)=C(C=C4O)O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)